2012 ©
             Publication
Journal Publication
Research Title Chrysin Ameliorates the Side Effect of Methotrexate Chemotherapy on Antioxidant Status and Neurogenesis in a Rat Model  
Date of Distribution 4 May 2023 
Conference
     Title of the Conference The 45th Annual Conference of the Anatomy Association of Thailand 
     Organiser Department of Anatomy, Faculty of Medicine, Chiang Mai University, Anatomy Association of Thailand (AAT) 
     Conference Place Suan Bua Hotel & Resort, Chiang Mai 
     Province/State Chiang Mai, Thailand 
     Conference Date 3 May 2023 
     To 5 May 2023 
Proceeding Paper
     Volume 2023 
     Issue
     Page 20 
     Editors/edition/publisher
     Abstract Adult neurogenesis is a process of neural stem cell proliferation, migration and differentiation to be newborn neurons. Methotrexate (MTX) is a folic acid antagonist that is widely used as a chemotherapy agent in several types of cancer. However, neurotoxicity of MTX is considerably a major clinical side effect. Chrysin (CH) is a natural flavonoid with various biological properties such as antioxidant and neuroprotective effects. Therefore, the present study was designed to investigate the protective effect of CH against MTX-induced oxidative damage and neurogenesis impairment. Adult Sprague Dawley rats were randomly divided into four groups including vehicle, MTX, CH and MTX+CH groups. Chrysin (10 mg/kg) was administered by oral gavage for 15 days. Intravenous MTX (75 mg/kg) was applied followed by intraperitoneal injection of leucovorin (LCV) on day 8 and 15. The vehicle group received saline, propylene glycol and LCV. Subsequently, the hippocampal neurogenesis was evaluated using Ki67/RECA-1, nestin and Sox2 immunofluorescence staining in the subgranular layer of the dentate gyrus in the hippocampus. Furthermore, the level of oxidative stress marker or malondialdehyde (MDA) and the expression of antioxidant enzymes including superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase (CAT) in the hippocampus and prefrontal cortex were evaluated. The results demonstrated that treatment with CH ameliorated MTX-stimulated neurogenesis impairment by increasing the number of Ki67/RECA-1, nestin and Sox2 positive cells. In addition, CH enhanced the activity of SOD, GPx and CAT enzymes and decreased MDA level in the hippocampus and prefrontal cortex tissues. In conclusion, CH displays neuroprotective effects on MTX-induced neurogenesis impairment via upregulating antioxidant enzyme activity and downregulating oxidative stress. Thus, CH could be a potential therapeutic agent to prevent neurotoxicity of MTX. 
Author
647070013-7 Miss TANAPORN ANOSRI [Main Author]
Medicine Doctoral Degree

Peer Review Status ไม่มีผู้ประเมินอิสระ 
Level of Conference ชาติ 
Type of Proceeding Abstract 
Type of Presentation Oral 
Part of thesis true 
Presentation awarding false 
Attach file
Citation 0